In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes

Sarah Yoon Ai Ng,Doreen Zhu,William G. Herrington

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes

2020

Sarah Yoon Ai Ng
Doreen Zhu
William G. Herrington

Source Citation Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabet...

Keywords:

Kidney
Diabetes mellitus
Medicine
Cardiology
Internal medicine
Type 2 diabetes
MEDLINE
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations